Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07776015Completed
Randomised trial of Exomide in androgenetic alopecia (AGA) (2 arms), sponsored by Tanta University. Primary endpoint: Global Aesthetic Improvement Scale at 6 months. Started Apr 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07776015.